Table of Contents Author Guidelines Submit a Manuscript
Journal of Pharmaceutics
Volume 2017, Article ID 3690473, 5 pages
https://doi.org/10.1155/2017/3690473
Research Article

Formulation and Evaluation of New Glimepiride Sublingual Tablets

1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sana’a University, Sana’a, Yemen
2Department of Pharmacy, Faculty of Medicine and Health Sciences, Yemeni Jordanian University, Sana’a, Yemen
3Department of Pharmacy, Faculty of Medicine and Health Sciences, Thamar University, Dhamar, Yemen
4Department of Biomedical Science, Sana’a University, Sana’a, Yemen

Correspondence should be addressed to Wafa Al-Madhagi; moc.liamtoh@ijahdamla_w

Received 19 June 2016; Accepted 3 October 2016; Published 5 February 2017

Academic Editor: Francisco Javier Flores-Murrieta

Copyright © 2017 Wafa Al-Madhagi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Massi-Benedetti, “Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience,” Clinical Therapeutics, vol. 25, no. 3, pp. 799–816, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. S. N. Davis, “The role of glimepiride in the effective management of Type 2 diabetes,” Journal of Diabetes and its Complications, vol. 18, no. 6, pp. 367–376, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Frick, H. Moller, and E. Wirbitzki, “Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 46, no. 3, pp. 305–311, 1998. View at Publisher · View at Google Scholar
  4. S. Vidyadhara, J. R. Babu, R. Sasidhar et al., “Formulation and evaluation of glimepiride solid dispersions and their tablet formulations for enhanced bioavailability,” Pharmanest, vol. 2, no. 1, pp. 15–20, 2011, http://www.pharmanest.net. View at Google Scholar
  5. S. Vidyadhara, J. R. Babu, R. L. C. Sasidhar, A. Ramu, S. Siva Prasad, and M. Tejasree, “Formulation and evaluation of glimepiride solid dispersions and their tablet formulations for enhanced bioavailability,” Pharmanest-An International Journal of Advances in Pharmaceutical Sciences, vol. 2, pp. 15–20, 2011. View at Google Scholar
  6. O. Rachid, M. Rawas-Qalaji, F. E. R. Simons, and K. J. Simons, “Dissolution testing of sublingual tablets: a novel in vitro method,” AAPS PharmSciTech, vol. 12, no. 2, pp. 544–552, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Birudaraj, B. Berner, S. Shen, and X. Li, “Buccal permeation of buspirone: mechanistic studies on transport pathways,” Journal of Pharmaceutical Sciences, vol. 94, no. 1, pp. 70–78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Ishikawa, N. Koizumi, B. Mukai et al., “Pharmacokinetics of acetaminophen from rapidly disintegrating compressed tablet prepared using microcrystalline cellulose (PH-M-06) and spherical sugar granules,” Chemical and Pharmaceutical Bulletin, vol. 49, no. 2, pp. 230–232, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. T. M. Price, K. L. Blauer, M. Hansen, F. Stanczyk, R. Lobo, and G. W. Bates, “Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17β-estradiol,” Obstetrics and Gynecology, vol. 89, no. 3, pp. 340–345, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. S. C. Sweetman Martindale, The Complete Drug Reference, vol. 34, Pharmaceutical Press, 2005.
  11. L. V. Allen, “Rapid-dissolve technology: an interview with Loyd V. Allen,” International Journal of Pharmacy and Technology, vol. 7, pp. 449–450, 2003. View at Google Scholar
  12. Y. Fu, S. Yang, S. H. Jeong, S. Kimura, and K. Park, “Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 21, no. 6, pp. 433–476, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. S. Biradar, S. T. Bhagavati, and I. J. Kuppasad, “Fast dissolving drug delivery systems: a brief overview,” The Internet Journal of Pharmacology, vol. 4, no. 2, 2006. View at Google Scholar
  14. R. V. Keny, C. Desouza, and C. F. Lourenco, “Formulation and evaluation of rizatriptan Benzoate mouth disintegrating tablets,” Indian Journal of Pharmaceutical Sciences, vol. 72, no. 1, pp. 79–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Wayne, R. Dipan, and D. Ann, Selecting super disintegrants for Orally Disintegrating Tablet Formulations in Pharmaceutical Technology, 2006.
  16. British Pharmacopeia, 2011.
  17. United States pharmacopeia, 2007.